NewsEventsReports
NewsEventsReports
Submit Content
Get the latest delivered to your inbox
Privacy Policy
  1. Home
  2. /
  3. Members
  4. /
  5. Ultragenyx Pharmaceutical

Ultragenyx Pharmaceutical

    Ultragenyx Issues 2022 ESG Report, Continuing To Enhance Its Leadership on Corporate Responsibility Image

    POSTED 

    05-24-23

    Ultragenyx Issues 2022 ESG Report, Continuing To Enhance Its Leadership on Corporate Responsibility

    Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel products for rare and ultrarare diseases, today released its second annual ESG report.
    Ultragenyx Pharmaceutical logo

    Ultragenyx Pharmaceutical

    Ultragenyx Pharmaceutical

    Can't find what you're looking for?

    Join today and get the latest delivered to your inbox

    Privacy Policy